| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.2M | -86.9% |
| SG&A Expense | $11.0M | -51.8% |
| Operating Income | -$20.2M | +59.1% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$19.2M | +67.6% |
| Income Tax | -$203K | — |
| Net Income | -$19.0M | +67.9% |
| EPS (Basic) | -$0.34 | +74.4% |
| EPS (Diluted) | -$0.34 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.3M | -54.6% |
| Current Assets | $10.0M | -53.8% |
| Total Assets | $10.1M | -61.4% |
| Current Liabilities | $1.7M | -66.4% |
| Total Liabilities | $153.8M | -2.3% |
| Stockholders' Equity | -$148.0M | -12.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.1M | +72.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$46K | -100.2% |
| Financing Cash Flow | $2.2M | -92.9% |
| Free Cash Flow | -$12.1M | +73.0% |
| +74.4% |